These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1820916)

  • 21. In vitro characterization of the OptiChamber Diamond valved holding chamber.
    Hatley RH; von Hollen D; Sandell D; Slator L
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of propellant soluble drug from a metered dose inhaler.
    Ashworth HL; Wilson CG; Sims EE; Wotton PK; Hardy JG
    Thorax; 1991 Apr; 46(4):245-7. PubMed ID: 2038731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols.
    Kim CS; Eldridge MA; Sackner MA
    Am Rev Respir Dis; 1987 Jan; 135(1):157-64. PubMed ID: 3800143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug.
    O'Callaghan C; Lynch J; Cant M; Robertson C
    Thorax; 1993 Jun; 48(6):603-6. PubMed ID: 8346488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler.
    Farr SJ; Warren SJ; Lloyd P; Okikawa JK; Schuster JA; Rowe AM; Rubsamen RM; Taylor G
    Int J Pharm; 2000 Mar; 198(1):63-70. PubMed ID: 10722951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler.
    Farr SJ; Rowe AM; Rubsamen R; Taylor G
    Thorax; 1995 Jun; 50(6):639-44. PubMed ID: 7638806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disodium cromoglycate use in children and adolescents with asthma: correlation between plasma concentrations and protective effects for various inhalation methods.
    Kato Y; Muraki K; Fujitaka M; Sakura N; Ueda K
    Ann Allergy Asthma Immunol; 1999 Dec; 83(6 Pt 1):553-8. PubMed ID: 10619349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices.
    DeHaan WH; Finlay WH
    J Aerosol Med; 2001; 14(3):361-7. PubMed ID: 11693848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of therapeutic aerosols to intubated babies.
    Grigg J; Arnon S; Jones T; Clarke A; Silverman M
    Arch Dis Child; 1992 Jan; 67(1 Spec No):25-30. PubMed ID: 1536581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro deposition and clinical efficacy of two sodium cromoglycate inhalation powders.
    Vidgren P; Vidgren M; Laurikainen K; Pietilä T; Silvasti M; Paronen P
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):108-12. PubMed ID: 1906433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of deposition of inhaled aerosol in the respiratory tract of man using three-dimensional multimodality imaging and mathematical modeling.
    Fleming JS; Hashish AH; Conway JH; Nassim MA; Holgate ST; Halson P; Moore E; Bailey AG; Martonen TB
    J Aerosol Med; 1996; 9(3):317-27. PubMed ID: 10163661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metered-dose inhaler.
    Wilkes W; Fink J; Dhand R
    J Aerosol Med; 2001; 14(3):351-60. PubMed ID: 11693847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of temperature on the emitted dose of an oral metered dose inhaler.
    Williams RO; Barron MK
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1043-8. PubMed ID: 9876558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vibrating membrane devices deliver aerosols more efficient than standard devices: a study in a neonatal upper airway model.
    Tiemersma S; Minocchieri S; van Lingen RA; Nelle M; Devadason SG
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):280-6. PubMed ID: 23273244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    J Aerosol Med; 2005; 18(4):379-85. PubMed ID: 16379614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative lung bioavailability of generic sodium cromoglycate inhalers used with and without a spacer device.
    Aswania O; Chrystyn H
    Pulm Pharmacol Ther; 2001; 14(2):129-33. PubMed ID: 11273794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reservoir design and dose availability with long-term metered dose inhaler corticosteroid use.
    Rau JL; Zhu Y
    J Aerosol Med; 1998; 11(1):15-26. PubMed ID: 10177218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The physico-chemical basis of radiolabelling metered dose inhalers with 99mTc.
    Farr SJ
    J Aerosol Med; 1996 Mar; 9 Suppl 1():S27-36. PubMed ID: 10160055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sites of deposition of aqueous aerosols: a study of efficiency of delivery systems for lung ventilation imaging in man.
    Woolman PS; Coutts CT; Mole DR; Dendy PP; Higenbottam TW
    Nucl Med Commun; 1989 Mar; 10(3):171-80. PubMed ID: 2657514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.